Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebral Oxygen Saturation Measurement During Cardioversion Because of Atrial Fibrillation

NCT02378155 is registered in ClinicalTrials.gov with Hasselt University as lead sponsor.

NCT NCT02378155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02378155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebral Oxygen Saturation Measurement During Cardioversion Because of Atrial Fibrillation
Lead sponsor
Hasselt University
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2015
Completion date
Not reported
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electrical cardioversion of atrial fibrillation, pharmacological cardioversion of atrial fibrillation